Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites.

作者: Hua Zhao , Margaret R. Spitz , Karin M. Gwyn , Xifeng Wu

DOI: 10.1002/MC.10023

关键词: Microsomal epoxide hydrolaseRestriction fragment length polymorphismOdds ratioLung cancerBiologyInternal medicineExonMolecular biologyNon-Hispanic whitesEndocrinologyGenotypeCarcinogen

摘要: Microsomal epoxide hydrolase (mEPHX) is a critical metabolic enzyme involved in the activation and subsequent detoxification of specific tobacco carcinogens. mEPHX harbors polymorphisms exon 3 4 that modulate enzymatic activity. The polymorphism decreases activity, whereas increases We hypothesized lung cancer risk. Using case-control study design restriction fragment length polymerase chain reaction assay, we determined polymorphic genotypes 181 cases among non-Hispanic whites 163 controls (matched for age, sex, ethnicity, smoking history). Our results showed variant allele increased overall risk by 56% (odds ratio [OR] = 1.56, 95% confidence interval [CI] = 0.99–2.46). Additionally, estimates were elevated significantly younger people (< 64 yr) (OR = 2.27, CI = 1.15–4.50) current smokers (OR = 2.22, CI = 1.06–4.65). had no effect (OR = 0.88, CI = 0.56–1.38), but there was 53% protective (OR = 0.47, CI = 0.22–0.99) people. When analyzed together, those with high activity genotype an 1.72 (95% CI = 0.90–3.29). This also evident only These findings suggest these alleles modulates © 2002 Wiley-Liss, Inc.

参考文章(19)
Christine Bouchardy, Maria Reinikainen, Simone Benhamou, Pierre Dayer, Ari Hirvonen, Association between Lung Cancer and Microsomal Epoxide Hydrolase Genotypes Cancer Research. ,vol. 58, pp. 5291- 5293 ,(1998)
J M Sayer, H Yagi, P J van Bladeren, W Levin, D M Jerina, Stereoselectivity of microsomal epoxide hydrolase toward diol epoxides and tetrahydroepoxides derived from benz[a]anthracene. Journal of Biological Chemistry. ,vol. 260, pp. 1630- 1640 ,(1985) , 10.1016/S0021-9258(18)89641-7
K S Hudmon, M R Spitz, R M Chamberlain, W K Hong, H Jiang, W Xiang, W Gosbee, G Ferry, S E Honn, Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 6, pp. 565- 571 ,(1997)
Xiaomei Jin, Xifeng Wu, Jack A. Roth, Christopher I. Amos, Terri M. King, Cynthia Branch, Susan E. Honn, Margaret R. Spitz, Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype Carcinogenesis. ,vol. 16, pp. 2205- 2208 ,(1995) , 10.1093/CARCIN/16.9.2205
P. SIMS, P. L. GROVER, A. SWAISLAND, K. PAL, A. HEWER, Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide Nature. ,vol. 252, pp. 326- 328 ,(1974) , 10.1038/252326A0
Irene Persson, Inger Johansson, Qun-Ying Yue, Lian-Shan Duan, Leif Bertilsson, Magnus Ingelman-Sundberg, Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients International Journal of Cancer. ,vol. 81, pp. 325- 329 ,(1999) , 10.1002/(SICI)1097-0215(19990505)81:3<325::AID-IJC2>3.0.CO;2-S
Newton A.C.S Wong, Frances Rae, Andrew Bathgate, Christopher A.D Smith, David J Harrison, Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population Toxicology Letters. ,vol. 115, pp. 17- 22 ,(2000) , 10.1016/S0378-4274(00)00166-1